[1] Alzheimer’s Association, 2016. What is Alzheimer’s?http://wwwalzorg/alzheimers_disease_what_is_alzheimersasp.
[2] Caldeira GL, Ferreira IL, Rego AC, 2013 Jan. Impaired transcription in Alzheimer's disease: key role in mitochondrial dysfunction and oxidative stress. Journal of Alzheimer's Disease. 34(1):115-31.
[3] Simonian N, Coyle JT, 1996 Apr. Oxidative stress in neurodegenerative diseases. Annual review of pharmacology and toxicology. 36(1):83-106.
[4] Smith MA, Sayre LM, Monnier VM, Perry G, 1995. Radical ageing in Alzheimer’s disease. Trends Neurosci. 18(4):172–176. https://doi.org/10.1016/0166-2236 (95)93897-7.
[5] Julien C, Tremblay C, Émond V, Lebbadi M, Salem Jr N, Bennett DA, Calon F, 2009 Jan 1. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. Journal of Neuropathology & Experimental Neurology. 68(1):48-58.
[6] Kumar R, Chaterjee P, Sharma PK, Singh AK, Gupta A, Gill K, Tripathi M, Dey AB, Dey S, 2013 Apr 16 . Sirtuin1: a promising serum protein marker for early detection of Alzheimer’s disease. PloS one. 8(4):e61560.
[7] Wei W, Xu X, Li H, Zhang Y, Han D, Wang Y, Yan W, Wang X, Zhang J, Liu N, You Y, 2014 Jun 1 . The SIRT2 polymorphism rs10410544 and risk of Alzheimer’s disease: a meta-analysis. Neuromolecular medicine. 16(2):448-56.
[8] Singh KK, 2006 May. Mitochondria damage checkpoint, aging, and cancer. Annals of the New York Academy of Sciences. 1067(1):182-90.
[9] Sawada M, Carlson JC, 1987 Nov 1. Changes in superoxide radical and lipid peroxide formation in the brain, heart and liver during the lifetime of the rat. Mechanisms of ageing and development. 41(1-2):125-37.
[10] Rebrin I, Sohal RS, 2008 Oct 1. Pro-oxidant shift in glutathione redox state during aging. Advanced drug delivery reviews. 60(13-14):1545-52.
[11] Du L, Zhang X, Han YY, Burke NA, Kochanek PM, Watkins SC, Graham SH, Carcillo JA, Szabó C, Clark RS, 2003 May 16. Intra-mitochondrial poly (ADP-ribosylation) contributes to NAD+ depletion and cell death induced by oxidative stress. Journal of Biological Chemistry. 278(20):18426-33.
[12] Lin MT, Beal MF, 2006 Oct 19. Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature. 443(7113):787-95.
[13] Shekhar S, Yadav Y, Singh AP, Pradhan R, Desai GR, Dey AB, Dey S, 2018 Sep 1 . Neuroprotection by ethanolic extract of Syzygium aromaticum in Alzheimer's disease like pathology via maintaining oxidative balance through SIRT1 pathway. Experimental gerontology. 110:277-83.
[14] Kim SH, Lu HF, Alano CC, 2011 . Neuronal Sirt3 protects against excitotoxic injury in mouse cortical neuron culture. PloS one. 6(3).
[15] Cheng A, Yang Y, Zhou Y, Maharana C, Lu D, Peng W, Liu Y, Wan R, Marosi K, Misiak M, Bohr VA, 2016 Jan 12 . Mitochondrial SIRT3 mediates adaptive responses of neurons to exercise and metabolic and excitatory challenges. Cell metabolism. 23(1):128-42.
[16] Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG, 2014 Jun 1. Distinct patterns of sirtuin expression during progression of Alzheimer’s disease. Neuromolecular medicine. 16(2):405-14.
[17] Yin J, Han P, Song M, Nielsen M, Beach TG, Serrano GE, Liang WS, Caselli RJ, Shi J, 2018 Nov. Amyloid-β increases tau by mediating sirtuin 3 in Alzheimer’s disease. Molecular neurobiology. 55(11):8592-601.
[18] Zeng L, Yang Y, Hu Y, Sun Y, Du Z, Xie Z, Zhou T, Kong W, 2014 Feb 4. Age-related decrease in the mitochondrial sirtuin deacetylase Sirt3 expression associated with ROS accumulation in the auditory cortex of the mimetic aging rat model. PLoS One.9 (2):e88019.
[19] Weir HJ, Murray TK, Kehoe PG, Love S, Verdin EM, O’Neill MJ, Lane JD, Balthasar N, 2012. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer’s disease. PloS one. 7(11).
[20] Song W, Song Y, Kincaid B, Bossy B, Bossy-Wetzel E, 2013 Mar 1. Mutant SOD1G93A triggers mitochondrial fragmentation in spinal cord motor neurons: neuroprotection by SIRT3 and PGC-1α. Neurobiology of disease. 51:72-81.
[21] Zhu H, Guo Q, Mattson MP, 1999 Sep 18. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation. Brain research. 842(1):224-9.
[22] Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T, Smythe G, Sachdev P, Guillemin GJ, 2015 May 8. Differential expression of sirtuins in the aging rat brain. Frontiers in cellular neuroscience.9:167.
[23] Dutt Way W, Soga T, Parhar IS, 2015 Sep 16. Aging and chronic administration of serotonin-selective reuptake inhibitor citalopram upregulate Sirt4 gene expression in the preoptic area of male mice. Frontiers in genetics. 6:281.
[24] Schwer B, North BJ, Frye RA, Ott M, Verdin E, 2002 Aug 19. The human silent information regulator (Sir) 2 homologue hSIRT3 is a mitochondrial nicotinamide adenine dinucleotide–dependent deacetylase. The Journal of cell biology. 158(4):647-657.
[25] Michishita E, McCord RA, Berber E, Kioi M, Padilla-Nash H, Damian M, Cheung P, Kusumoto R, Kawahara TL, Barrett JC, Chang HY, 2008 Mar. SIRT6 is a histone H3 lysine 9 deacetylase that modulates telomeric chromatin. Nature. 452(7186):492-496.
[26] Braidy N, Poljak A, Grant R, Jayasena T, Mansour H, Chan-Ling T, Smythe G, Sachdev P, Guillemin GJ, 2015 May 8. Differential expression of sirtuins in the aging rat brain. Frontiers in cellular neuroscience. 9:167.
[27] Toiber D, Erdel F, Bouazoune K, Silberman DM, Zhong L, Mulligan P, Sebastian C, Cosentino C, Martinez-Pastor B, Giacosa S, D’Urso A, 2013 Aug 22 . SIRT6 recruits SNF2H to DNA break sites, preventing genomic instability through chromatin remodeling. Molecular cell. 51(4):454-68.
[28] Jung ES, Choi H, Song H, Hwang YJ, Kim A, Ryu H, Mook-Jung I, 2016 May 9. p53-dependent SIRT6 expression protects Aβ42-induced DNA damage. Scientific reports. 6(1):1-1.
[29] Kaluski S, Portillo M, Besnard A, Stein D, Einav M, Zhong L, Ueberham U, Arendt T, Mostoslavsky R, Sahay A, Toiber D, 2017 Mar 28 . Neuroprotective functions for the histone deacetylase SIRT6. Cell reports. 18(13):3052-62.
[30] McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM, 1984 Jul 1. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS‐ADRDA Work Group* under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology.34 (7):939.
[31] Pradhan R, Kumar R, Shekhar S, Rai N, Ambashtha A, Banerjee J, Pathak M, Dwivedi SN, Dey S, Dey AB, 2017 Sep 1. Longevity and healthy ageing genes FOXO3A and SIRT3: Serum protein marker and new road map to burst oxidative stress by Withania somnifera. Experimental gerontology.95:9-15.
[32] Julien C, Tremblay C, Émond V, Lebbadi M, Salem Jr N, Bennett DA, Calon F, 2009 Jan 1. Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease. Journal of Neuropathology & Experimental Neurology. 68(1):48-58.
[33] Lutz MI, Milenkovic I, Regelsberger G, Kovacs GG, 2014 Jun 1. Distinct patterns of sirtuin expression during progression of Alzheimer’s disease. Neuromolecular medicine. 16(2):405-414.
[34] Lutz, M.I.; Milenkovic, I.; Regelsberger, G.; Kovacs, G.G, 2014. Distinct patterns of sirtuin expression during progression of Alzheimer’s disease. Neuromol. Med. 16, 405–414.
[35] Han P, Tang Z, Yin J, Maalouf M, Beach TG, Reiman EM, Shi J, 2014 Sep 1. Pituitary adenylate cyclase-activating polypeptide protects against β-amyloid toxicity. Neurobiology of aging. 35(9):2064-2071.
[36] Lattanzio F, Carboni L, Carretta D, Candeletti S, Romualdi P, 2016 May 1. Treatment with the neurotoxic Aβ (25–35) peptide modulates the expression of neuroprotective factors Pin1, Sirtuin 1, and brain-derived neurotrophic factor in SH-SY5Y human neuroblastoma cells. Experimental and toxicologic pathology. 68(5):271-276.
[37] Weir HJ, Murray TK, Kehoe PG, Love S, Verdin EM, O’Neill MJ, Lane JD, Balthasar N, 2012. CNS SIRT3 expression is altered by reactive oxygen species and in Alzheimer’s disease. PloS one. 7(11).
[38] Rulten SL, Caldecott KW, 2013 Aug 1. DNA strand break repair and neurodegeneration. DNA repair. 12(8):558-67.